Cardiovascular disease (CVD) still ranks as the top cause of mortality worldwide. Lipid-modifying therapy has revolutionized the treatment of the disease and is partly responsible for the recent decline in deaths due to CVD. Treatment strategies have evolved since the introduction of the earlier lipid-lowering agents (fibrates, niacin, bile acid resins) to the advent of statins, which have become the standard drugs in cholesterol therapy. The strategy of using high-intensity statin therapy as the initial treatment approach in high-risk individuals, rather than focusing on specific cholesterol levels alone, remains a subject of debate.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccl.2010.10.002DOI Listing

Publication Analysis

Top Keywords

cardiovascular disease
8
lipid-lowering therapy
4
therapy statins
4
statins primary
4
primary secondary
4
secondary prevention
4
prevention cardiovascular
4
disease cardiovascular
4
disease cvd
4
cvd ranks
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!